Story
Shineway Pharmaceutical Declares Special Interim Dividend of RMB 0.85 Per Share

Shineway Pharmaceutical Group Ltd. (HK: 02877) will distribute a special interim dividend of RMB 0.85 per share for the 2026 fiscal year. The company has scheduled the payment date for October 15, 2026.
Dividend Details
According to a company announcement reported by Zhitong Finance, the board of directors approved the one-time shareholder distribution. This payment is classified as a special interim dividend, meaning it is separate from the company's regular dividend cycle and is being issued before the finalization of full-year financial results.
The key details are as follows:
- Company: Shineway Pharmaceutical Group Ltd.
- Stock Code: 02877
- Dividend Amount: RMB 0.85 per share
- Payment Date: October 15, 2026
AdSignificance for Investors
The declaration of a special dividend often indicates that a company has generated profits or cash flow in excess of its normal operational needs and planned investments. Such distributions are a direct way to return value to shareholders.
By issuing the payment as an interim dividend, the company's management may be signaling confidence in its financial performance and stability during the current fiscal year. The announcement did not specify the record date for shareholders to be eligible for the dividend.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.

Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.

Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.

DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.